|View printer-friendly version|
|July 13, 2017 11:38 a.m.|
|Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders|
"We greatly appreciate the support of Teva's shareholders as we work to
strengthen the leadership of Teva, with the addition of these
distinguished Board members, and our ongoing search to find the best
chief executive officer to lead Teva,” stated Dr.
Dr. Barer continued, “We are pleased to have added these world class
directors to our Board from both
Four New Independent Directors Join the Teva Board
Results from the 2017 Annual Meeting of Shareholders
All proposals were approved by the required majority of shareholders, by the following percentages of shares voting:
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to:
Teva Pharmaceutical Industries Ltd.